Trial · NCT05353348
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Haemoglobin level on postoperative day 5 | Haemoglobin level on postoperative day 5 | Haemoglobin level on postoperative day 5 |
| Secondary | Amount of allogeneic blood products used in the perioperative period | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | (red blood cells, plasma, platelets) |
| Secondary | Effect of combination therapy on changes in perioperative haemoglobin levels | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Pre-intervention versus post-operative haemoglobin |
| Secondary | Effect of combination therapy on changes in perioperative ferritin levels | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Pre-intervention versus post-operative ferritin |
| Secondary | Effect of combination therapy on changes in perioperative reticulocyte levels | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Magnitude of reticulocyte elevation |
| Secondary | Incidence of perioperative acute renal insufficiency | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Postoperative creatinine more than 2 times higher than preoperative or oliguria (\<0.5ml/kg/h) within 12 hours |
| Secondary | Post-operative intensive care unit stay | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Length of stay in ICU after surgery |
| Secondary | Infusion reactions and allergies | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Perioperative allergic events |
| Secondary | Incidence of serious adverse events (SAEs) in the perioperative period up to 6 months after surgery | Through study completion, an average of 1.5 year | Myocardial infarction、Ischemic cerebral infarction、arrhythmia、Deep vein thrombosis of the lower extremity、Pulmonary embolism, etc |
| Secondary | All-cause mortality within 6 months of surgery | Through study completion, an average of 1.5 year | Incidence of mortality |
| Secondary | Total length of hospital stay | Through study completion, an average of 1 year | Total length of hospital stay |
| Secondary | Incidence of perioperative infections | Through study completion, an average of 1 year | Non-prophylactic use of antibiotics |
| Secondary | Health Care Costs | From admission until hospital discharge or postoperative day 30, whichever comes first | All medical costs during hospitalisation |
| Secondary | Post-operative hospital readmission rate | Through study completion, an average of 1 year | Post-operative hospital readmission rate |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05353348/registered